Research on model analyses derived from clinical specimens in early clinical trials

Research on model analyses derived from clinical specimens in early clinical trials - NCCH Phase1 Model Analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049499

Enrollment

800

Registered

2022-11-14

Start date

2022-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects enrolled or be considered for enrollment in early clinical trials.

Exclusion criteria

Exclusion criteria: Subjects reject exploratory analyses using clinical specimens.

Design outcomes

Primary

Measure	Time frame
To investigate the efficacy and validity of identifying optimal population and biomarkers that predict the occurrence of adverse events in early clinical trials according to the results of the comprehensive analysis of genetic analyses and immunological profiling	—

Countries

Japan

Contacts

Public ContactJun Sato

National Cancer Center Hospital Department of Experimental Therapeutics

junsato2@ncc.go.jp+81-3-3542-2511

Outcome results